Evidence map›Paper›PMID 38750698›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2024

Combined genetic-pharmacologic inactivation of tightly linked ADAMTS proteases in temporally specific windows uncovers distinct roles for versican proteolysis and glypican-6 in cardiac development.

Timothy J Mead, Sumit Bhutada, Simon J Foulcer, Niccolò Peruzzi, Courtney M Nelson, Deborah E Seifert, Jonathan Larkin, Karin Tran-Lundmark, Jorge Filmus, Suneel S Apte

Abstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Physiology (Bethesda, Md.) · 2026
    Review
  2. Article
  3. Article
  4. An Overview of ADAMTS Proteases.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Timothy J MeadDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, USA; University Hospitals Rainbow Babies and Children's Hospital, Cleveland, OH, USA. Electronic address: tjm192@case.edu.
Sumit BhutadaDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Simon J FoulcerDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Niccolò PeruzziDepartment of Experimental Medical Science, and Wallenberg Center for Molecular Medicine Lund University and The Pediatric Heart Center, Skane University Hospital, Lund, Sweden.
Courtney M NelsonDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Deborah E SeifertDepartment of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Jonathan LarkinSynOA Therapeutics, Philadelphia, PA 19119, USA.
Karin Tran-LundmarkDepartment of Experimental Medical Science, and Wallenberg Center for Molecular Medicine Lund University and The Pediatric Heart Center, Skane University Hospital, Lund, Sweden.
Jorge FilmusSunnybrook Research Institute and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Suneel S ApteDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA. Electronic address: aptes@ccf.org.

Funding

VERSICAN PROTEOLYSIS AND REGULATION OF VASCULAR SMOOTH MUSCLEP01HL107147 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI HASCALL, VINCENT CHARLES · 2011 to 2017
$16.1M
Impact of microfibril turnover on vascular development and diseaseR01HL156987 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI Timothy Joseph Mead · 2022 to 2026
$2.0M
High-End Instrumentation (HEI) Grant Program (S10)S10OD023436 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2017 to 2017
$873k
Quadrupole Time-of-Flight LC-MSS10OD030398 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2021 to 2021
$530k
NHLBI NIH HHS P01 HL107147NHLBI NIH HHS R01 HL156987NIH HHS S10 OD023436NIH HHS S10 OD030398
6 · The paper itself

Abstract

Extracellular matrix remodeling mechanisms are understudied in cardiac development and congenital heart defects. We show that matrix-degrading metalloproteases ADAMTS1 and ADAMTS5, are extensively co-expressed during mouse cardiac development. The mouse mutants of each gene have mild cardiac anomalies, however, their combined genetic inactivation to elicit cooperative roles is precluded by tight gene linkage. Therefore, we coupled Adamts1 inactivation with pharmacologic ADAMTS5 blockade to uncover stage-specific cooperative roles and investigated their potential substrates in mouse cardiac development. ADAMTS5 blockade was achieved in Adamts1 null mouse embryos using an activity-blocking monoclonal antibody during distinct developmental windows spanning myocardial compaction or cardiac septation and outflow tract rotation. Synchrotron imaging, RNA in situ hybridization, immunofluorescence microscopy and electron microscopy were used to determine the impact on cardiac development and compared to Gpc6 and ADAMTS-cleavage resistant versican mutants. Mass spectrometry-based N-terminomics was used to seek relevant substrates. Combined inactivation of ADAMTS1 and ADAMTS5 prior to 12.5 days of gestation led to dramatic accumulation of versican-rich cardiac jelly and inhibited formation of compact and trabecular myocardium, which was also observed in mice with ADAMTS cleavage-resistant versican. Combined inactivation after 12.5 days impaired outflow tract development and ventricular septal closure, generating a tetralogy of Fallot-like defect. N-terminomics of combined ADAMTS knockout and control hearts identified a cleaved glypican-6 peptide only in the controls. ADAMTS1 and ADAMTS5 expression in cells was associated with specific glypican-6 cleavages. Paradoxically, combined ADAMTS1 and ADAMTS5 inactivation reduced cardiac glypican-6 and outflow tract Gpc6 transcription. Notably, Gpc6

Indexed as

ADAMTS1 ProteinADAMTS5 ProteinGlypicansHeartProteolysisVersicansAnimalsGene Expression Regulation, DevelopmentalHeart Defects, CongenitalMiceMice, KnockoutADAMTS1 ProteinAdamts1 protein, mouseADAMTS5 ProteinAdamts5 protein, mouseGlypicansVcan protein, mouseVersicansDegradomicsGlypicanMetalloproteaseProteoglycanTerminomicsVersican

Identifiers

PMID38750698
PMCPMC11526477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.